Wael Abdelhalim Reda

Learn More
Gamma Knife treatment is traditionally limited to tumours with a diameter not exceeding 3–3.5 cm. The current paper presents 97 patients with meningiomas with a minimum volume of 10 cm3, treated with a prescription dose of 12 Gy (or sometimes less to protect neighbouring structures). The post-treatment assessment of these patients, the early response to(More)
A 24-year-old male patient was treated with Gamma Knife surgery (GKS) for medial temporal lobe epilepsy. The treatment parameters were in accordance with established practice. Epilepsy stopped after 2 years and medication was discontinued. Four years later, he developed a profound radionecrosis leading to blindness. As had refused surgical intervention his(More)
The relationship between target volume and adverse radiation effects (AREs) at low prescription doses requires elucidation. The development of AREs in three series of patients treated in the Gamma Knife is analysed in relation to prescription dose and target volume. There were three groups. In group 1, there were of 275 patients with meningiomas; in group(More)
  • 1